Top Stories
-
In a Phase 2a clinical trial, Columbia researchers found that the drug AEFO117 significantly reduced the effects of cannabis in daily cannabis smokers.
Topic
-
As therapists, when we’re at our best, we’re doing more than understanding and responding, the process requires an act of creativity, of imagination.
Topic
-
Check out Columbia-affiliated faculty presentations at the 2023 American Psychiatric Association Annual Meeting in San Francisco.
Topic
-
A Columbia study finds that adolescents who use cannabis recreationally are two to four times as likely to develop psychiatric disorders then teens who don’t use cannabis at all.
Topic
